MYRIAD GENETICS, INC. Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
MYRIAD GENETICS, INC. (MYGN) reported Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities of $29.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2026-02-24
- MYRIAD GENETICS, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2025 was $29.50M.
- MYRIAD GENETICS, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2024 was $0.00.
- MYRIAD GENETICS, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- MYRIAD GENETICS, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2022 was $700.00K, a 86.27% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 6 month | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $29.50M 10-K · filed 2026-02-24 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-02-24 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-24 | ||
| 2022-12-31 | $700.00K 10-K · filed 2025-02-28 | ||
| 2021-12-31 | $5.10M 10-K · filed 2024-02-28 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | ||
| 2020-06-30 | $0.00 10-K · filed 2023-03-01 | ||
| 2019-06-30 | $2.70M 10-K · filed 2022-02-25 | ||
| 2018-06-30 | $0.00 10-KT · filed 2021-03-16 | ||
| 2011-06-30 | $997.00K 10-K · filed 2013-08-14 | -$997.00K 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |